Nobel Biocare Holding AG (Nobel Biocare Holding AG) Capex-to-Operating-Income : 0.20 (As of Dec. 2013)

Nobel Biocare Holding AG Capex-to-Operating-Income Chart

Nobel Biocare Holding AG Annual Data
	Trend	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13
Capex-to-Operating-Income		Get a 7-Day Free Trial					0.16	0.32	0.25	0.15	0.20

Nobel Biocare Holding AG Semi-Annual Data
	Dec02	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13
Capex-to-Operating-Income	Get a 7-Day Free Trial							0.16	0.32	0.25	0.15	0.20

Competitive Comparison of Nobel Biocare Holding AG's Capex-to-Operating-Income

For the Medical Instruments & Supplies subindustry, Nobel Biocare Holding AG's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nobel Biocare Holding AG's Capex-to-Operating-Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nobel Biocare Holding AG's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Nobel Biocare Holding AG's Capex-to-Operating-Income falls into.

Nobel Biocare Holding AG Capex-to-Operating-Income Calculation

Nobel Biocare Holding AG's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2013 is calculated as

Nobel Biocare Holding AG's Capex-to-Operating-Income for the quarter that ended in Dec. 2013 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nobel Biocare Holding AG  (OTCPK:NBHGF) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.

Nobel Biocare Holding AG Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Nobel Biocare Holding AG's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Business Description